Petros Pharmaceuticals, Inc. Contracts & Agreements

57 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Amendment Agreement, dated March 30, 2025, by and between Petros Pharmaceuticals, Inc. and the investors party thereto
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Termination Agreement, dated as of March 31, 2025, by and between Vivus LLC and Metuchen Pharmaceuticals LLC
Termination Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Description of Capital Stock
Stock Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Securities Purchase Agreement, dated February 17, 2025, by and between Petros Pharmaceuticals, Inc. and the investors party thereto
Purchase Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Series B Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Series A Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Pre-Funded Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Securities Purchase Agreement
Purchase Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Series A Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Series B Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Securities Purchase Agreement
Purchase Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Series B Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Series A Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Second Amendment to Amended and Restated Petros Pharmaceuticals, Inc. 2020 Omnibus Incentive Compensation Plan (incorporated by reference to Exhibit 10.1 to the Company's Current...
Bonus & Incentive Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Series A Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Series B Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Pre-Funded Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Securities Purchase Agreement
Purchase Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Lock-Up Agreement
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Amendment Agreement, dated January 23, 2025, by and between Petros Pharmaceuticals, Inc. and the investors party thereto
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2025
Form of Amendment Agreement, dated November 13, 2024, by and between Petros Pharmaceuticals, Inc. and the investors party thereto
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2024
Offer Letter Amendment, effective as of October 16, 2024, by and between the Company and Fady Boctor
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2024
Form of Amendment Agreement, dated October 11, 2024, by and between Petros Pharmaceuticals, Inc. and the investors party thereto
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2024
Form of Omnibus Waiver and Amendment, dated March 21, 2024, by and between Petros Pharmaceuticals, Inc. and the investors party thereto
Waiver Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2024
First Amendment to Amended and Restated Petros Pharmaceuticals, Inc. 2020 Omnibus Incentive Compensation Plan
Bonus & Incentive Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2023
Form of Registration Rights Agreement
Registration Rights Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Form of Purchase Agreement
Purchase Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Form of Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Amendment No. 1 to License and Commercialization Agreement, dated January 18, 2022, between Metuchen Pharmaceuticals LLC and VIVUS LLC, a Delaware limited liability company
License Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2022
Promissory Note, dated January 18, 2022, by Metuchen Pharmaceuticals LLC in favor or VIVUS LLC, a Delaware limited liability company
Note Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Settlement Agreement, dated January 18, 2022, between Metuchen Pharmaceuticals LLC and VIVUS LLC, a Delaware limited liability company
Settlement Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
DESCRIPTION OF CAPITAL STOCK
Stock Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
DE
2022
Severance and General Release Agreement, dated March 1, 2022, between Andrew Gesek and Petros Pharmaceuticals, Inc., its affiliates, subsidiaries and successor entities
Severance Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2022
Amendment No. 1 to License and Commercialization Agreement, dated January 18, 2022, between Metuchen Pharmaceuticals LLC and VIVUS LLC, a Delaware limited liability company
License Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2022
Security Agreement, dated January 18, 2022, between Metuchen Pharmaceuticals LLC and VIVUS LLC, a Delaware limited liability company
Security Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Promissory Note, dated January 18, 2022, by Metuchen Pharmaceuticals LLC in favor or VIVUS LLC, a Delaware limited liability company
Note Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Settlement Agreement, dated January 18, 2022, between Metuchen Pharmaceuticals LLC and VIVUS LLC, a Delaware limited liability company
Settlement Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2022
Form of Securities Purchase Agreement
Purchase Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Form of Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2021
Second Amendment to the Petros Pharmaceuticals, Inc. 2020 Omnibus Incentive Compensation Plan
Bonus & Incentive Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2021
Form of Securities Purchase Agreement
Purchase Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Form of Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2021
Form of Securities Purchase Agreement
Purchase Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Form of Investor Warrant
Warrant Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2021
Letter Agreement, dated as of March 31, 2021, by and between Metuchen Pharmaceuticals, LLC and Hybrid Medical LLC
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2021
Letter Agreement, dated as of September 24, 2020, by and between the Company and Hybrid Medical LLC
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2021
License Agreement, dated as of March 14, 2020, by and between the Company and Hybrid Medical LLC
License Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Third Amendment to Loan and Security Agreement, dated as of September 30, 2020, by and between the Company, Pos-T-Vac, LLC, Timm Medical Technologies, LLC, the lenders a party...
Loan Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2021
Second Amendment to Loan and Security Agreement, dated as of April 13, 2020, by and between the Company, Pos-T-Vac, LLC, Timm Medical Technologies, LLC, the lenders a party...
Loan Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
2021
First Amendment to Loan and Security Agreement, dated as of November 22, 2017, by and between the Company, the lenders a party thereto from time to time, and Hercules Capital, Inc
Loan Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
CA
2021
Loan and Security Agreement, dated as of September 30, 2016, by and between the Company, the lenders a party thereto from time to time, and Hercules Capital, Inc
Loan Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Description of Capital Stock
Stock Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Form of Petros Pharmaceuticals, Inc. Nonqualified Stock Option Grant Agreement
Stock Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Employment Offer Letter, entered into as of February 19, 2021, by and between Petros Pharmaceuticals, Inc. and Fady Boctor
Employment Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Separation Agreement, entered into as of December 24, 2020, by and between the Company and Keith Lavan
Separation Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
NJ
2020
Bonus Agreement, entered into as of December 11, 2020, by and between Petros Pharmaceuticals, Inc. and Fady Boctor
Bonus & Incentive Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020
Registration Rights Agreement, dated as of December 1, 2020, by and among Petros Pharmaceuticals, Inc. and JCP III SM AIV, L.P
Registration Rights Agreements
Petros Pharmaceuticals, Inc.
Pharmaceuticals
DE
2020